Popular on Rezul
- Music Producer Debuts Riveting Miniseries About a Pro Football Superstar Embroiled in Physical Assault Scandal
- The "Courtyard by Marriott Tokyo Ginza Hotel" has Renewed its Contract with Tobu Hotel Management
- Vision One Research Appoints Casinelli
- Klozers Bolsters Leadership Team with Appointment of Marc Smit as General Manager to Drive Expansion
- Certified Nutraceuticals Granted US Patent for Novel Method of Freeze-Drying Jellyfish Collagen
- Renowned Addiction Expert and Traumatologist Releases New Book on Addiction, Trauma, and Families
- Welcome Our Newest Client Periodontist: Raymond L. Wright Jr. DDS, Bing + Google Searches List 'BEST' in San Clemente & South Orange County, CA
- Cravens Logistics Center leases 249,370 square foot Class A distribution building with two tena
- Blue Brick Title and Escrow: A Revolutionary Approach to Title Insurance Combining Tradition with Modern Technology
- L.A.I. Communications Wins Prestigious Platinum MarCom Award for Excellence in Marketing and Communications
Similar on Rezul
- National Minority Health Association Launches "Equity for All."
- SalonInteractive Launches in Square App Marketplace to Provide eCommerce, Marketing & More to Beauty Professionals
- The Samuel Lawrence Foundation Presents Live from Dubai: First Friday Series Webinar on Dec 1
- Woburn Dentistry Provides Comprehensive Perio Procedures From One Convenient Location
- Study Finds Lotus Vaping Technologies' Flavored E-Liquids Reduce Smokers' Cigarettes Per Day at Significantly Higher Rate Than Tobacco Flavor
- L2 Aviation and Klatt Works announce MOU for the revolutionary aircraft Smoke Assured Vision Enhanced Display (SAVED) Safety System
- Patriot Urgent Care Opens Much Needed Urgent Care Clinic in Fort Washington
- IntellaTriage Hires Director of Engineering
- Fuel 4 Ever Unveils Innovative Collagen Protein Bars, Revolutionizing Healthy Snacking
- Zeelool Launches One-of-a-kind Fashion Statement Candy Glasses
'Spot Detective' – Check your spots this summer
Rezul News/10607747
The latest campaign urging Australians to get their skin checked
MELBOURNE, Australia & SYDNEY - Rezul -- OncoBeta, a leading medical device company specialising in innovative epidermal radioisotope therapies for non-melanoma skin cancer, has launched The Spot Detective campaign to rally Australians in the fight against skin cancer this summer.
With two out of three Australians diagnosed with skin cancer before the age of 701, it is vital for all Australians to have regular skin checks. The Spot Detective campaign is encouraging Australians to visit a Spot Detective – their GP, dermatologist or skin health specialist – to have their spots assessed and to learn about the various treatments available for those diagnosed with non-melanoma skin cancer.
Skin cancer occurs when skin cells are damaged, often from overexposure to ultraviolet (UV) radiation from the sun. There are three main types of skin cancer: basal cell carcinoma (BCC); squamous cell carcinoma (SCC) and melanoma.2 Australia has one of the highest melanoma rates in the world1, with one Australian dying from melanoma every six hours.3 A skin check can save your life.
OncoBeta's Australian Medical Director, Dr Sam Vohra, says, "Thankfully most skin cancers are treatable and most of us will know someone who has had a skin cancer. Today, there are a range of treatments available to patients in addition to surgery, some of which are painless*, only needing a single session† and non-invasive."4-6
The Spot Detective campaign is asking Australians to take action: if they see a skin spot that is suspicious, new, oddly shaped or has changed in colour then it's time to get it checked. The campaign includes a series of LIVE reads across 2GB and WSFM in Sydney and 3AW and Gold 104.3 in Melbourne, as well as a social media and digital marketing campaign, and free skin check pop-ups at various locations.
More on Rezul News
"With one of the highest incidences of skin cancer in the world, Australians need to be vigilant with their skin. The Spot Detective campaign is a timely reminder to make sure you are protecting yourself from the sun, and if you notice any changes to your skin, check in with a skin health specialist," added Dr Vohra.
Another health initiative from OncoBeta, this public awareness campaign also encourages anyone diagnosed with non-melanoma skin cancer to be well informed about all treatments and discuss their most suitable options with a healthcare professional. OncoBeta's skin cancer therapy which utilises the rhenium-188 isotope is now available at private clinics at Melbourne and Sydney. Patients with difficult anatomic localisations of a tumour, such as the ear, nose or anywhere on the face, and those with larger lesions problematic for plastic surgery, may benefit from this non-invasive solution.
To find out more information on skin cancer, and to learn what treatments are available, visit: www.spotdetective.com.au
About OncoBeta® GmbH
OncoBeta® GmbH, with its headquarters located in Garching near Munich, Germany, is a privately held medical device company, specializing in the development and commercialization of state-of-the-art, innovative therapies. Since its foundation, OncoBeta has concentrated its efforts on the development, regulatory approval(s) and commercialization of the epidermal radioisotope therapy Rhenium-SCT® (Skin Cancer Therapy), targeting NMSCs. OncoBeta has perfected the customized application and device management system in conformity with all health, safety and environmental protection regulatory standards.
Find out more about the Rhenium-SCT® at www.oncobeta.com
Follow us on social media:
More on Rezul News
LinkedIn: https://www.linkedin.com/company/oncobeta-gmbh/
Facebook: https://www.facebook.com/oncobeta/
Instagram: https://www.instagram.com/oncobeta_gmbh/
Forward-looking statements
This announcement includes forward-looking statements that involve risks, uncertainties and other factors, many of which are outside of OncoBeta's control, and which could cause actual results to differ materially from the results discussed in the forward-looking statements. Forward-looking statements include statements concerning OncoBeta's plans, objectives, goals, future events, performance and/or other information that is not historical information. All such forward-looking statements are expressly qualified by these cautionary statements and any other cautionary statements which may accompany the forward-looking statements. OncoBeta undertakes no obligation to publicly update or revise forward-looking statements to reflect subsequent events or circumstances after the date made, except as required by law.
*No reported pain.3
†Complete tumour regression in 98.5% of lesions treated.
References:
1. Cancer Council. Understanding Skin Cancer. January 2020. https://www.cancercouncil.com.au/ (accessed October 2022).
2. Skin Cancer. Available at https://www.mayoclinic.org/diseases-conditions/skin-cancer/symptoms-causes/syc-20377605 [Accessed October 2022]
3. Melanoma Institute Australia. Melamoma Facts. https://melanoma.org.au/about-melanoma/melanoma-facts/ (accessed October 2022).
4. Castellucci P, et al. Eur J Nucl Med Mol Imaging. 2021; 48(5):1511–1521.
5. Cipriani C, et al. J Dermatol Treat. 2020; DOI: 10.1080/09546634.2020.1793890.
6. Cipriani C, et al. In Therapeutic Nuclear Medicine. 2014. RP Baum (Ed), New York: Springer.
With two out of three Australians diagnosed with skin cancer before the age of 701, it is vital for all Australians to have regular skin checks. The Spot Detective campaign is encouraging Australians to visit a Spot Detective – their GP, dermatologist or skin health specialist – to have their spots assessed and to learn about the various treatments available for those diagnosed with non-melanoma skin cancer.
Skin cancer occurs when skin cells are damaged, often from overexposure to ultraviolet (UV) radiation from the sun. There are three main types of skin cancer: basal cell carcinoma (BCC); squamous cell carcinoma (SCC) and melanoma.2 Australia has one of the highest melanoma rates in the world1, with one Australian dying from melanoma every six hours.3 A skin check can save your life.
OncoBeta's Australian Medical Director, Dr Sam Vohra, says, "Thankfully most skin cancers are treatable and most of us will know someone who has had a skin cancer. Today, there are a range of treatments available to patients in addition to surgery, some of which are painless*, only needing a single session† and non-invasive."4-6
The Spot Detective campaign is asking Australians to take action: if they see a skin spot that is suspicious, new, oddly shaped or has changed in colour then it's time to get it checked. The campaign includes a series of LIVE reads across 2GB and WSFM in Sydney and 3AW and Gold 104.3 in Melbourne, as well as a social media and digital marketing campaign, and free skin check pop-ups at various locations.
More on Rezul News
- Kingston NY-Based Ryan & Ryan Kicks Off its 65th Anniversary Dec. 6 by Underwriting a Chamber of Commerce Mixer Saluting RUPCO
- Kuester Management Group Reflects on Options for Accommodating Electric Vehicles in HOAs
- Tobu Railway's Hosts "Tokyo Downtown Tour: Bamboo Lighting."
- "Street Fighter™ 6" Panel Announced for December 2nd at Los Angeles Comic Con; The Music of Street Fighter 6: A Special Look at the Video Game
- North America's Agrivoltaics Expo Set to Level Up the Solar Land Use Renaissance Next Summer in Chicago
"With one of the highest incidences of skin cancer in the world, Australians need to be vigilant with their skin. The Spot Detective campaign is a timely reminder to make sure you are protecting yourself from the sun, and if you notice any changes to your skin, check in with a skin health specialist," added Dr Vohra.
Another health initiative from OncoBeta, this public awareness campaign also encourages anyone diagnosed with non-melanoma skin cancer to be well informed about all treatments and discuss their most suitable options with a healthcare professional. OncoBeta's skin cancer therapy which utilises the rhenium-188 isotope is now available at private clinics at Melbourne and Sydney. Patients with difficult anatomic localisations of a tumour, such as the ear, nose or anywhere on the face, and those with larger lesions problematic for plastic surgery, may benefit from this non-invasive solution.
To find out more information on skin cancer, and to learn what treatments are available, visit: www.spotdetective.com.au
About OncoBeta® GmbH
OncoBeta® GmbH, with its headquarters located in Garching near Munich, Germany, is a privately held medical device company, specializing in the development and commercialization of state-of-the-art, innovative therapies. Since its foundation, OncoBeta has concentrated its efforts on the development, regulatory approval(s) and commercialization of the epidermal radioisotope therapy Rhenium-SCT® (Skin Cancer Therapy), targeting NMSCs. OncoBeta has perfected the customized application and device management system in conformity with all health, safety and environmental protection regulatory standards.
Find out more about the Rhenium-SCT® at www.oncobeta.com
Follow us on social media:
More on Rezul News
- Titan Pressure Washing Demonstrates the Difference Between a Pressure Wash and a Soft Wash on Tile Roofs
- National Minority Health Association Launches "Equity for All."
- Green Office Partner Launches Managed Print Services Program in Canada
- Lake Lanier Living in Stunning Modern Farmhouse Design from O'Dwyer Homes at Chattahoochee Res
- Vantiva Confirms its Strong Commitment to Diversity, Equity and Inclusion
LinkedIn: https://www.linkedin.com/company/oncobeta-gmbh/
Facebook: https://www.facebook.com/oncobeta/
Instagram: https://www.instagram.com/oncobeta_gmbh/
Forward-looking statements
This announcement includes forward-looking statements that involve risks, uncertainties and other factors, many of which are outside of OncoBeta's control, and which could cause actual results to differ materially from the results discussed in the forward-looking statements. Forward-looking statements include statements concerning OncoBeta's plans, objectives, goals, future events, performance and/or other information that is not historical information. All such forward-looking statements are expressly qualified by these cautionary statements and any other cautionary statements which may accompany the forward-looking statements. OncoBeta undertakes no obligation to publicly update or revise forward-looking statements to reflect subsequent events or circumstances after the date made, except as required by law.
*No reported pain.3
†Complete tumour regression in 98.5% of lesions treated.
References:
1. Cancer Council. Understanding Skin Cancer. January 2020. https://www.cancercouncil.com.au/ (accessed October 2022).
2. Skin Cancer. Available at https://www.mayoclinic.org/diseases-conditions/skin-cancer/symptoms-causes/syc-20377605 [Accessed October 2022]
3. Melanoma Institute Australia. Melamoma Facts. https://melanoma.org.au/about-melanoma/melanoma-facts/ (accessed October 2022).
4. Castellucci P, et al. Eur J Nucl Med Mol Imaging. 2021; 48(5):1511–1521.
5. Cipriani C, et al. J Dermatol Treat. 2020; DOI: 10.1080/09546634.2020.1793890.
6. Cipriani C, et al. In Therapeutic Nuclear Medicine. 2014. RP Baum (Ed), New York: Springer.
Source: OncoBeta GmbH
0 Comments
Latest on Rezul News
- Advcash adds instant Pix payments in Brazil
- Floris United Methodist Church announces first-ever mission trip for people with disabilities
- Sip Social Co. Partners With Omnify To Streamline User Experience Across Growing Operations
- Fred Nassiri Relaunches "Love Sees No Colour"
- Navigating Market Trends: Expert Insights for Investors
- David Weekley Homes Delivered a Holiday Bounty to Georgia's Making A Way Housing
- The Samuel Lawrence Foundation Presents Live from Dubai: First Friday Series Webinar on Dec 1
- Wohler makes the Evertz Quartz Protocol available for their iAM-SUM audio monitors & iVAM-SUM AV monitors
- Genuine Hospitality, LLC Adds Two, Southwest Florida Hotels, to Growing Portfolio
- The CPSE Shenzhen 2023 was inaugurated on October
- Bill Edwards Foundation for the Arts and Ericka Dunlap Collaborate with Local Nonprofits to Celebrate Diversity at Mahaffey
- New York Young Republican Club Endorses Allen Mashburn For Lieutenant Governor Of North Carolina
- Diane Gray-Smith Joins STS Capital Partners
- Harbor Associates/Evergen Equity Acquire Los Angeles Industrial RE Portfolio for $55 Million
- Event Raises $54,825 for HBA DOC Scholarship Program
- PMUniversity Now Offers Emerging Tech Training As An Authorized Training Partner With Certnexus
- San Diego-based life sciences company buys Dunedin industrial property for $3.9 million
- Woburn Dentistry Provides Comprehensive Perio Procedures From One Convenient Location
- Celebrating 25 Year of Being Wright
- Historic Worcester Quarry Property in Prospect, Maine, Listed for $2.3 Million